ccinfoadmin

EQALM recommendations for the analytical performance specifications for blood smear interpretation in haematology: a need for standardizationStéphanie Albarèdeon September 23, 2025 at 10:00 am

by

Clin Chem Lab Med. 2025 Sep 24. doi: 10.1515/cclm-2025-1011. Online ahead of print. ABSTRACT OBJECTIVES: The European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM) Haematology Working Group (WG) has previously provided two guidelines to support the standardization of haematology blood smear external quality assessment (EQA) (Vives CJL, Albarède S, Flandrin G, Heller … Read more

Evaluation of urine albumin-to-creatinine ratio analysis using strip test as a screening method for urinary albumin determination in primary care​Paula Liébanas Garcíaon September 22, 2025 at 10:00 am

by

Adv Lab Med. 2025 May 1;6(3):345-350. doi: 10.1515/almed-2024-0068. eCollection 2025 Sep. ABSTRACT OBJECTIVES: The determination of urinary albumin, crucial for chronic kidney disease (CKD) diagnosis and monitoring, typically employs quantitative techniques as the gold standard. However, semi-quantitative methods such as urine reagent strips show promise as cost-effective and rapid screening tools. This study aims to … Read more

Evaluación del análisis de la relación albúmina-creatinina mediante tira reactiva como método de cribado para la determinación de albúmina en orina en atención primaria​Paula Liébanas Garcíaon September 22, 2025 at 10:00 am

by

Adv Lab Med. 2025 Aug 15;6(3):351-357. doi: 10.1515/almed-2025-0102. eCollection 2025 Sep. NO ABSTRACT PMID:40977822 | PMC:PMC12446917 | DOI:10.1515/almed-2025-0102

Real-time immunophenotypic shifts in pediatric B lymphoblastic leukemia providing implications for minimal residual disease detection​Omer Javedon September 22, 2025 at 10:00 am

by

Adv Lab Med. 2025 May 5;6(3):358-364. doi: 10.1515/almed-2024-0202. eCollection 2025 Sep. ABSTRACT OBJECTIVES: Disease monitoring in acute leukemia management is crucial for risk stratification and chemotherapy response assessment. Minimal residual disease (MRD) testing is the most reliable tool, measuring antigenic expression differences between leukemic cells, hematogones, and mature benign B-cells. Modulation of antigen expression during … Read more

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 520